Examining the Utility of Performing Sentinel Node Biopsies for T1 Melanomas with Breslow Depths between 0.75 and 1.0 mm: A Review of a 20 Year Experience

This study evaluated a series of patient data with T1 melanoma to determine, in those cases where Breslow depth is between 0.75 mm and 1 mm, whether Sentinel Lymph Node Biopsy (SLNBx) is necessary or beneficial. This study represents a chart-review based retrospective analysis of over 1500 patients of Dr. William Jewell accrued over a period of 20 years (1986-2005) at the University of Kansas Medical Center. Of these 1500 patients, over 300 patients received wide excision and subsequent SLNBx. Thirty of these patients fell within the 0.75 to 1.0 mm Breslow depth and had the necessary SLNBx performed. 6% of those with Breslow depths between 0.75 and 1.0 mm had a positive SLNBx compared to 20% of those melanomas with depths between 1 and 2 mm. Furthermore, Clark’s level of IV or greater suggested a greater likelihood of positivity at the SLN for T1 melanoma. Citation: Hughes K, Jewell W, Brown CS (2015) Examining the Utility of Performing Sentinel Node Biopsies for T1 Melanomas with Breslow Depths between 0.75 and 1.0 mm: A Review of a 20 Year Experience. J Clin Dermatol Ther 2: 013.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  2015-11-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.24966/cdt-8771/100013
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognosis for patients with thin cutaneous melanoma

  2003cited by this paper
• Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas.

  2003cited by this paper
• Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group

  2002cited by this paper
• Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group. J Pathol; 197: 188–193

  2002cited by this paper
• The predictive value of the sentinel lymph node in malignant melanomas.

  2001cited by this paper
• Sentinel Lymph Node Biopsy in the Management of Patients With Primary Cutaneous Melanoma: Review of a Large Single-Institutional Experience With an Emphasis on Recurrence

  2001cited by this paper
• Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

  2001cited by this paper
• Developing indications for the use of sentinel lymph node biopsy and adjuvant high-dose interferon alfa-2b in melanoma.

  2001cited by this paper
• Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement.

  2001cited by this paper
• Detection of micrometastasis in sentinel lymph nodes of patients with primary cutaneous melanoma.

  2001cited by this paper
• High proliferative activity may predict early metastasis of thin melanomas.

  2001cited by this paper
• Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre study

  2001influential reference
• Clinico‐pathological features of relapsing very thin melanoma

  2001cited by this paper
• Reliability of the Sentinel Node Procedure in Melanoma Patients: Analysis of Failures After Long-Term Follow-Up

  2000cited by this paper
• Thin #1 mm Level III and IV Melanomas Are Higher Risk Lesions For Regional Failure and Warrant Sentinel Lymph Node Biopsy

  2000cited by this paper
• Sentinel lymph node biopsy in patients with primary cutaneous melanoma: study of 455 cases

  2000cited by this paper
• Lymphedema after sentinel lymph node biopsy for cutaneous melanoma: a report of 5 cases.

  2000cited by this paper
• Sentinel Lymph Node Biopsy for Melanoma: Experience with 234 Consecutive Procedures

  2000cited by this paper
• How many lymph nodes are enough during sentinel lymphadenectomy for primary melanoma?

  2000cited by this paper
• Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.

  1999cited by this paper
• Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.

  1999cited by this paper
• Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes

  1998cited by this paper
• Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.

  1998cited by this paper
• Pathologic examination of the sentinel lymph node.

  1997cited by this paper
• Radioguided surgery for the ultrastaging of the patient with melanoma.

  1997cited by this paper
• Lymphatic mapping and sentinel node biopsy in patients with malignant melanoma.

  1997cited by this paper
• Intraoperative identification of sentinel lymph node in patients with malignant melanoma.

  1997cited by this paper
• Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of clark's level for prognostic classification

  1995cited by this paper
• Influence of level and depth on recurrence rate in thin melanomas.

  1993cited by this paper
• "Thin" malignant melanoma: risk factors and clinical management.

  1992cited by this paper
• Technical details of intraoperative lymphatic mapping for early stage melanoma.

  1992cited by this paper
• Lethal “Thin” Malignant Melanoma: Identifying Patients at Risk

  1988cited by this paper

• No citing papers are available for this paper.